Posted by Michael Wonder on 08 Apr 2020
Cows come home for CSL in COVID-19 vaccine battle
8 April 2020 - It sounds like a pitch for a sci-fi thriller — using genetically modified cows to fight coronavirus.
But that is exactly what Australia’s biggest health company, CSL, is doing under a new partnership with US biotech SAB Biotherapeutics.
CSL, via its subsidiary CSL Behring, is investing in SAB’s development of a “high-targeted” immunotherapy to treat COVID-19 infected patients without the need for human plasma donations.
